Description:
THANATOPHORIC DYSPLASIA; TD
FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
| Class |
Disorders of Connective Tissue, Muscle, and Bone |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Race
|
White
|
|
Family Member
|
1
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
1 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| MUTATION VERIFICATION |
The gene mutation in this cell line was confirmed by sequencing and FRET probe analysis. |
| |
| Gene |
FGFR3 |
| Chromosomal Location |
4p16.3 |
| Allelic Variant 1 |
134934.0005; THANATOPHORIC DYSPLASIA, TYPE I; TD1 |
| Identified Mutation |
ARG248CYS; Of 39 individuals with type I thanatophoric dysplasia (187600), Tavormina et al. (1995) found an arg248-to-cys mutation in 22 and a ser371-to-cys mutation (134934.0006) in 1. Both of these mutations were in the extracellular region of the protein. Amino acid substitution resulted from a C-to-T transition at nucleotide 742.
Although type II thanatophoric dysplasia cases have been found to have a single recurrent K650E change (134934.0004), type I cases have different mutations affecting either the extracellular or intracellular domains of FGFR3. However, mutations in the FGFR3 gene were identified in only approximately 60% of the type I TD cases. These findings, and the range of symptoms observed, suggested that type I TD is heterogeneous in genetic background. Pokharel et al. (1996) described a Japanese type I TD patient followed for more than 9 years. They found that the patient had the arg248-to-cys mutation as did 4 other Japanese cases of type I TD. No association was found with the ser371-to-cys mutation.
|
| Remarks |
Short-limbed platyspondylia; megalencephaly; temporal lobe dysplasia; bellshaped thorax; shortened ribs and long bones; bowed femora; kyphosis; parents are GM10893 and 10894 Lymphoid; donor subject has a C>T transition at nucleotide 742 in exon 6 of the FGFR3 gene (742C>T) resulting in a substitution of cysteine for arginine at codon 248 [Arg248Cys (R248C)] |
| Passage Frozen |
1 |
| Split Ratio |
1:5 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|